Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom s New CEO to Earn $420K Per Year, Up to $210K in Performance Bonus

NEW YORK, June 3 (GenomeWeb News) - Harry Stylli, Sequenom's newly hired president and CEO, will receive an annual salary of $420,000 and be eligible for an annual performance bonus of up to 50 percent of that salary.

 

When he starts his new job on June 6, Stylli will be eligible to purchase 1 million shares of stock at a price per share equal to the fair market value on his start date, Sequenom said in an SEC filing this week.

 

Stylli will replace Stephen Zaniboni, Sequenom's chief financial officer who has served as acting-CEO since February when Toni Schuh stepped down.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.